Moderna announced the Food and Drug Administration (FDA) will review its new mRNA flu vaccine, changing course less than two weeks after the agency said it refused to accept Moderna's application. In ...

The U.S. Food and Drug Administration (FDA) refused to consider Moderna’s application for a new flu vaccine using mRNA technology, the company announced Tuesday, a decision that could delay the ...

On Friday, the Centers for Disease Control and Prevention updated recommendations for booster shots, saying that people who got the Moderna vaccine should now seek out a booster five months after ...

The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA flu vaccine candidate after holding a high-priority meeting with the company.

WASHINGTON (AP) — The Food and Drug Administration will consider whether to approve Moderna's new flu vaccine after all, resolving a dispute that had blocked the company's application for the first-of ...

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...

An advisory committee to the US Food and Drug Administration (FDA) voted unanimously to recommend a half-strength booster dose of the mRNA COVID-19 developed by Moderna and the National Institutes of ...